EP 0696202 A1 19960214 - PHARMACEUTICAL COMPOSITION CONTAINING THYMOCTONAN AND AZT
Title (en)
PHARMACEUTICAL COMPOSITION CONTAINING THYMOCTONAN AND AZT
Title (de)
KOMBINATIONSPRÄPARAT, DAS THYMOCTONAN UND AZT ENTHÄLT
Title (fr)
COMPOSITIONS PHARMACEUTIQUES CONTENANT DU THYMOCTONAN ET DE L'AZT
Publication
Application
Priority
- EP 9500653 W 19950223
- GB 9403856 A 19940301
Abstract (en)
[origin: WO9523610A1] The combined use of thymoctonan and an antiretroviral agent such as AZT in the treatment of retroviral disease, notably AIDS and ARC (AIDS-related complex), is disclosed.
IPC 1-7
IPC 8 full level
A61K 38/00 (2006.01); A61K 38/08 (2019.01); A61K 31/70 (2006.01); A61K 45/06 (2006.01); A61P 31/12 (2006.01); A61P 31/18 (2006.01); C07K 7/06 (2006.01)
CPC (source: EP KR US)
A61K 38/08 (2013.01 - EP KR US); A61P 31/12 (2017.12 - EP); A61P 31/18 (2017.12 - EP)
Citation (search report)
See references of WO 9523610A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI NL PT SE
DOCDB simple family (publication)
WO 9523610 A1 19950908; AU 1759295 A 19950918; CA 2160248 A1 19950908; EP 0696202 A1 19960214; FI 955181 A0 19951030; FI 955181 A 19951030; GB 9403856 D0 19940420; HU 9503432 D0 19960129; HU T73178 A 19960628; IL 112803 A0 19950526; JP H08509993 A 19961022; KR 960701652 A 19960328; MX 9504565 A 19970531; NO 954171 D0 19951019; NO 954171 L 19951019; PL 311340 A1 19960205; ZA 951654 B 19951208
DOCDB simple family (application)
EP 9500653 W 19950223; AU 1759295 A 19950223; CA 2160248 A 19950223; EP 95910515 A 19950223; FI 955181 A 19951030; GB 9403856 A 19940301; HU 9503432 A 19950223; IL 11280395 A 19950227; JP 52267295 A 19950223; KR 19950704771 A 19951031; MX 9504565 A 19950223; NO 954171 A 19951019; PL 31134095 A 19950223; ZA 951654 A 19950228